| | Publication Year | Title | Author(s) |
| 1 | 6-Feb-2014 | Mistaken identity: granular cell astrocytoma masquerading as histiocytosis of the central nervous system. | Campbell, Robert N; Liew, Mun Sem; Gan, Hui K ; Cher, Lawrence M |
| 2 | 12-Aug-2013 | Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma. | Batchelor, Tracy T; Mulholland, Paul; Neyns, Bart; Nabors, L Burt; Campone, Mario; Wick, Antje; Mason, Warren; Mikkelsen, Tom; Phuphanich, Surasak; Ashby, Lynn S; Degroot, John; Gattamaneni, Rao; Cher, Lawrence M ; Rosenthal, Mark A; Payer, Franz; Jürgensmeier, Juliane M; Jain, Rakesh K; Sorensen, A Gregory; Xu, John; Liu, Qi; van den Bent, Martin |
| 3 | 17-Sep-2012 | A single centre study of the treatment of relapsed primary central nervous system lymphoma (PCNSL) with single agent temozolomide. | Wong, S F; Gan, Hui K ; Cher, Lawrence M |
| 4 | 8-Feb-2010 | A phase II trial of primary temozolomide in patients with grade III oligodendroglial brain tumors. | Gan, Hui K ; Rosenthal, Mark A; Dowling, Anthony; Kalnins, Renate M; Algar, Elizabeth; Wong, Nicholas; Benson, Angela; Woods, Anne-Marie; Cher, Lawrence M |
| 5 | 24-Dec-2009 | Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab. | Gan, Hui K ; Azad, Arun A; Cher, Lawrence M ; Mitchell, Paul L R |
| 6 | 7-Oct-2009 | Primary anaplastic pilocytic astrocytoma. | Azad, Arun A; Deb, Siddhartha; Cher, Lawrence M |
| 7 | 31-Jan-2008 | The use of chemotherapy in patients with gliomas: patterns of care in Victoria from 1998-2000. | Cher, Lawrence M ; Rosenthal, Mark A; Drummond, Katharine J; Dally, Michael; Murphy, Michael; Ashley, David M; Thursfield, Vicky; Giles, Graham G |
| 8 | 1-Mar-2006 | Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies. | Cher, Lawrence M ; Murone, Carmel ; Lawrentschuk, Nathan; Ramdave, Shanker; Papenfuss, Anthony; Hannah, Anthony; O'Keefe, Graeme J; Sachinidis, John I; Berlangieri, Salvatore U ; Fabinyi, Gavin C ; Scott, Andrew M |
| 9 | 1-Aug-1999 | KRN8602 (MX2-hydrochloride): an active new agent for the treatment of recurrent high-grade glioma. | Clarke, K; Basser, R L; Underhill, C; Mitchell, Paul L R ; Bartlett, John; Cher, Lawrence M ; Findlay, M; Dalley, D; Pell, M; Byrne, M; Geldard, H; Hill, J S; Maher, D; Fox, R M; Green, M D; Kaye, A H |